Epadel OTC Switch Approved With Condition Of Appropriate Use Survey
This article was originally published in PharmAsia News
Executive Summary
Japan’s Pharmaceuticals Affairs and Food Sanitation Council’s Committee on Non-prescription Drugs decided that the switch of Mochida Pharmaceuticals hyperlipidemia drug Epadel to an over-the-counter drug will be approved on the condition that a survey on appropriate use is carried out.